Wrinkle Filler Hyaluronic Acid

Hyaluronic acid dermal filler for wrinkle correction and facial volume restoration at MEDICOM Clinic Brno. Targets nasolabial folds, marionette lines, under-eye hollows, and midface volume loss using density-matched HA gels for natural, long-lasting results.

Wrinkle treatment with hyaluronic acid filler at MEDICOM Clinic Brno addresses the two main drivers of visible facial ageing: volume deflation and structural descent. As subcutaneous fat compartments atrophy and facial bones remodel over time, the skin loses its underlying scaffold — producing folds, hollows, and sagging that cannot be corrected by topical skincare alone. HA fillers restore lost tissue volume and provide mechanical support to overlying skin. The most common treatment areas are the nasolabial folds (lines running from the nose to the corners of the mouth), the marionette lines (vertical lines descending from the mouth corners), the tear trough and infraorbital hollow (sunken appearance under the eyes), the cheeks and midface, and the temples. The choice of HA product is matched to the depth of injection: high-viscosity, high-G-prime gels are used for deep structural support in the cheeks and midface, while softer, lower-viscosity gels are preferred for superficial wrinkles and delicate areas like the tear trough. Treatment is performed after topical anaesthetic application. Most HA products also contain lidocaine, reducing discomfort during injection. Depending on the treatment area, the physician uses needle or cannula technique. Cannulas are increasingly preferred for vascular risk areas (midface, temples, tear trough) as they reduce the chance of intravascular injection compared to sharp needles. Results are immediate and continue to improve as swelling resolves over 1–2 weeks. Duration varies by area and product density: cheek volume typically lasts 12–18 months, nasolabial folds 9–12 months, and softer superficial products 6–9 months. All HA fillers used at MEDICOM are reversible with hyaluronidase injection.